Clinical Trial Update September/October 2026 - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical Trial Update September/October 2026

  • September 1, 2026

  • 46 min

Share

Objective:

To provide an overview of active clinical trials in age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and uveitis.

Approach:
  • Wet AMD Trials: Listing of completed trials including NT-101 and OCS-01 eye drops.
  • Dry AMD Trials: Overview of new trials assessing dietary interventions and various treatments for geographic atrophy.
Key Findings:
  • The trials for NT-101 and OCS-01 eye drops for wet AMD are completed.
  • Multiple new studies have been initiated for dry AMD focusing on dietary interventions and pharmacological treatments.
  • Trials include various designs such as randomized, double-masked, and multicenter studies.
Limitations:
  • The article does not provide detailed results or outcomes from the completed trials.
  • Limited information on the methodologies and participant demographics of the studies.
Sources:

Original Source(s)

Related Content